Related Experiment Video
Updated: Jul 8, 2026
10:52
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
CDKN1A protects medium spiny neurons from Huntington's disease pathology
Seong Won Lee1, Trinity J Upshaw1, Diandra J Bailey2
1Department of Biomedical Sciences, Mercer University School of Medicine, Columbus, GA 31901, USA.
Neurobiology of Disease
|July 6, 2026
Summary
Reduced CDKN1A expression contributes to Huntington's disease (HD) pathology by increasing neuronal vulnerability. Restoring CDKN1A levels in patient-derived neurons alleviates HD symptoms and enhances survival.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is caused by CAG repeat expansion in the HTT gene, leading to mutant huntingtin (mHTT) aggregation and neurodegeneration.
- The specific mechanisms causing selective vulnerability of medium spiny neurons (MSNs) in HD, especially with aging, are not fully understood.
Purpose of the Study:
- To investigate the mechanisms underlying selective MSN vulnerability in Huntington's disease.
- To identify potential therapeutic targets for enhancing neuronal resilience in HD.
Main Methods:
- Generated patient-derived medium spiny neurons (MSNs) from fibroblasts of HD patients and controls using miR-9/9*-124 reprogramming.
- Performed multi-omics analysis (RNA-seq and ATAC-seq) on generated HD-MSNs and pre-HD-MSNs.
- Manipulated CDKN1A expression in HD-MSNs and pre-HD-MSNs to assess its role in HD pathology.
Main Results:
- Reduced CDKN1A expression and promoter accessibility were observed in HD-MSNs compared to pre-HD-MSNs.
- Overexpression of CDKN1A in HD-MSNs reduced DNA damage, mHTT aggregates, and improved neuronal survival and autophagy.
- Knockdown of CDKN1A in pre-HD-MSNs worsened HD pathologies, indicating a protective role for CDKN1A.
Conclusions:
- Reduced CDKN1A expression is a potential contributor to MSN vulnerability in Huntington's disease.
- CDKN1A modulates neuronal resilience in HD by influencing DNA damage response and autophagy.
- CDKN1A represents a potential therapeutic target for Huntington's disease.
